SODIUM FLUORIDE F 18 injection Stany Zjednoczone - angielski - NLM (National Library of Medicine)

sodium fluoride f 18 injection

mayo clinic - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 91.5 mci in 1 ml - sodium fluoride f 18 injection usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection usp has the potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection usp. prior to the administration of sodium fluoride f 18 injection usp to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection usp should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection usp is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f 18 injection usp or not to administer sodium fluoride f 18 injection usp, taking into account the importance of the drug to the mother. the body of scientific information related to radioactivity decay, drug tissue distribution and drug elimination shows that less than 0.01% of the radioactivity administered remains in the body after 24 hours (10 half-lives). to minimize the risks to a nursing infant, interrupt nursing for at least 24 hours. in reported clinical experience in approximately 100 children, weight-based doses (2.1 mbq/kg) ranging from 19 mbq-148 mbq (0.5-4 mci) were used. sodium fluoride f 18 was shown to localize to areas of bone turnover including rapidly growing epiphyses in developing long bones. children are more sensitive to radiation and may be at higher risk of cancer from sodium fluoride f 18 injection usp.

SODIUM FLUORIDE F 18- sodium fluoride f-18 injection, solution Stany Zjednoczone - angielski - NLM (National Library of Medicine)

sodium fluoride f 18- sodium fluoride f-18 injection, solution

biomedical research foundation of northwest louisiana - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproduction studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f

SODIUM FLUORIDE F18 injection Stany Zjednoczone - angielski - NLM (National Library of Medicine)

sodium fluoride f18 injection

cardinal health 414, llc - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f-18 injection, usp, is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none any radiopharmaceutical including sodium fluoride f-18 injection, usp, has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f-18 injection, usp. prior to the administration of sodium fluoride f-18 injection, usp, to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f-18 injection, usp, should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f-18 injection, usp, is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration o

Compound Sodium Lactate Intravenous Infusion BP, Ecobag (Hartmann’s Solution) Irlandia - angielski - HPRA (Health Products Regulatory Authority)

compound sodium lactate intravenous infusion bp, ecobag (hartmann’s solution)

b. braun medical limited - sodium chloride; potassium chloride; sodium lactate solution; calcium chloride dihydrate - solution for infusion - per cent - solutions affecting the electrolyte balance; electrolytes

FLUORIDE - fluoride tablet, chewable Stany Zjednoczone - angielski - NLM (National Library of Medicine)

fluoride - fluoride tablet, chewable

mayne pharma inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg - active ingredient: 0.5 mg of fluoride ion from 1.1 mg of sodium fluoride (naf). inactive ingredients: lactose, saccharine, grape flavor and magnesium stearate.

SODIUM FLUORIDEF 18 F 18- sodium fluoride f-18 injection Stany Zjednoczone - angielski - NLM (National Library of Medicine)

sodium fluoridef 18 f 18- sodium fluoride f-18 injection

children's hospital of michigan - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f-18 200 mg in 1 ml - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproduction studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f 18 i

OSTEOVISION SOLUTION Kanada - angielski - Health Canada

osteovision solution

centre for probe development and commercialization - sodium fluoride f 18 - solution - 11.1gbq - sodium fluoride f 18 11.1gbq - roentgenography

HARTMANN'S SOLUTION COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP Irlandia - angielski - HPRA (Health Products Regulatory Authority)

hartmann's solution compound sodium lactate intravenous infusion bp

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - 6/0.27/0.4 grams - electrolytes

HARTMANN'S SOLUTION COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP Irlandia - angielski - HPRA (Health Products Regulatory Authority)

hartmann's solution compound sodium lactate intravenous infusion bp

maco pharma (uk) ltd - sodium chloride ; calcium chloride dihydrate ; potassium chloride ; sodium lactate solution 60% - solution for infusion - grams - electrolytes